LUCD Earnings Lucid Diagnostics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–14 of 14
| Q3 2025 | 2025-09-30 | -0.59 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.52 | 2025-08-12 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.52 | 2025-05-13 | 10-Q |
| FY 2024 | 2024-12-31 | -1.05 | 2025-03-24 | 10-K |
| Q3 2025 | 2024-09-30 | -0.87 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.62 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.40 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -1.26 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -1.01 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.67 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.40 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -1.55 | 2024-03-25 | 10-K |
| Q3 2023 | 2022-09-30 | -1.15 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.76 | 2023-08-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.